While there are conflicting reports in the literature regarding how this SNP effects the function and accumulation of clusterin, there are multiple studies indicating that that increased levels of clusterin in the plasma of AD patients, regardless of the presence of a SNP at the CLU locus, correlates with a more rapid cognitive decline and an increase in brain atrophy [11, 50–52]. This evidence concerns the gene CLU and Mental deterioration.